Repligen Corp (RGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Repligen Corp (RGEN)

RGEN 163.71

+1.0%

2:23 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Douglas who wrote (69)	5/4/1998 12:07:00 PM
From: mark alan rosenberg	Read Replies (1) of 395

I may as well reignite this thread. RGEN is up 70% today. It broke a new high for the last 2 1/2 years. Anybody who knows anything about Repligen would know that this company has been working on Angiogenesis (tumor shrinkage) for a number of years. The co. is in trials for the product, but I'm not sure what phase? Also, RGEN owns and operates a scalable manufacturing facility for a substance called "Protien A". I'm not sure this factor plays into "necrosis" of tumors, but you may want to look into it. The co. is located in Cambridge, Mass where a lot of this technology originated. I am not a promotor. I did buy the stock today. Caveat emptor. Mark

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next